BIOE 301 Lecture Nine - PowerPoint PPT Presentation

About This Presentation
Title:

BIOE 301 Lecture Nine

Description:

Title: BME 301 Author: Rebecca richards-Kortum Last modified by: javierd Created Date: 12/16/2003 10:39:34 PM Document presentation format: On-screen Show – PowerPoint PPT presentation

Number of Views:149
Avg rating:3.0/5.0
Slides: 54
Provided by: Rebeccari67
Category:

less

Transcript and Presenter's Notes

Title: BIOE 301 Lecture Nine


1
BIOE 301 Lecture Nine
  • Amit Mistry
  • Feb 8, 2007

2
BIOE 301 Lecture 9
  • WARM-UP
  • What type of immune defense is involved in each
    of the following
  • A flu virus infects your cells
  • You step on a rusty nail and it pierces your skin
  • Youre exposed to chicken pox (you already had it
    as a kid)

3
Summary of Lecture 8
  • Pathogens Bacteria and Virus
  • Levels of Immunity
  • Barriers ? First line of defense
  • Innate ? Inflammation
  • Phagocytes
  • Complement
  • Adaptive ? Immunologic memory
  • Antibody mediated immunity
  • Cell mediated immunity ? Pathogens within cells

4
Q3 How can technology solve health care
problems?
  • CS1 Prevention of infectious disease

5
Outline
  • Pathogens How They Cause Disease
  • The Immune System How We Fight Disease
  • How Vaccines Work
  • The Power of Vaccines Childhood Illnesses
  • Designing a New Vaccine HIV/AIDS

6
Roadmap of CS 1
  • Science
  • Organisms that cause disease
  • Immunity
  • Engineering
  • How to make a vaccine
  • Vaccines From idea to product
  • Societal Impact
  • Health and economics
  • Ethics of clinical trials
  • Developed world/Developing world

7
Influenza Pandemic
  • CDC Public Service Announcement
  • http//www.pandemicflu.gov/
  • 1918-19 Spanish Flu
  • 50-100 million deaths
  • 1957-58 Asian Flu
  • 1-4 million deaths
  • 1968-69 Hong Kong Flu
  • 750,000 deaths

www.cdc.gov
http//en.wikipedia.org/wiki/Pandemic
8
Viruses
  • Three basic problems each must solve
  • How to reproduce inside a human cell
  • How to spread from one person to another
  • Inhale
  • Eat
  • During birth
  • Intimate physical contact
  • How to evade the immune system

http//students.washington.edu/grant/random/sneeze
.jpg
9
Influenza
  • Viral Reproduction - 1
  • Must get inside human cell to use cells
    biosynthetic machinery
  • Influenza virus binds to cell receptor
  • Induces receptor mediated endocytosis

10
Influenza
  • Viral Reproduction - 2
  • pH slowly reduced in endosome, due to proton pump
    in membrane
  • Virus releases its single stranded RNA and
    polymerase proteins
  • RNA segments and polymerase proteins enter
    nucleus of infected cell
  • Cell begins to make many copies of the viral RNA
    and viral coat proteins

11
Influenza
  • Viral Reproduction - 3
  • New viral particles exit nucleus and bud from
    cell
  • Viral polymerase proteins dont proofread
    reproduction
  • Nearly every virus produced in an influenza
    infected cell is a mutant

12
Influenza
  • Viral Spread
  • Infected person sneezes or coughs
  • Micro-droplets containing viral particles inhaled
    by another person
  • Penetrates epithelial cells lining respiratory
    tract
  • Influenza kills cells that it infects
  • Can only cause acute infections
  • Cannot establish latent or chronic infections
  • How does it evade immune extinction?
  • Antigenic drift
  • Caused by point mutations
  • http//www.cdc.gov/flu/weekly/usmap.htm

13
Influenza
  • How does the virus cause symptoms?
  • Cells of respiratory tract are killed by virus or
    immune system
  • Resulting inflammation triggers cough reflex to
    clear airways of foreign invaders
  • Influenza infection results in production of
    large quantities of interferon
  • Interferon protein that
    fights infection, but also causes

Fever Muscle aches Headaches Fatigue
14
Genetic Shift and Flu Pandemics
  • Genetic Shift
  • Animals co-infected by different strains of virus
  • Viral gene segments randomly reassociate
  • Reassortment of virus segments from birds, pigs,
    etc is source of new strains that infect humans
  • How does this happen?
  • Virus shed in bird feces, gets into pigs'
    drinking water
  • Humans handle and/or cough on the pig
  • New virus - segments from humans, birds pigs
  • China
  • Breeding ground for new influenzas strains
  • Proximity of humans, pigs, and ducks in China
  • Asian flu, Hong Kong flu, etc.
  • http//www.cdc.gov/flu/avian/facts.htm

15
Why do we need vaccines?
Pathogen Offense Immune System
Defense Vaccines ? Stealing the
playbook
16
Vaccination
  • Vaccination
  • Practice of artificially inducing immunity
  • Goal of vaccination
  • Stimulate both cell mediated and antibody
    mediated immunity that will protect the
    vaccinated person against future exposure to
    pathogen
  • Want the vaccine to have
  • Maximum realism
  • Minimum danger

17
What is needed to make memory cells?
  • Memory B Cells Memory Helper T Cells
  • B and T cell receptors must see virus or viral
    debris
  • Memory Killer T Cells
  • Antigen Presenting Cells must be infected with
    virus

18
History of Vaccination
  • Seventh Century
  • Indian Buddhists drank snake venom to induce
    immunity (through toxoid effect)
  • 1700s
  • Variolation against smallpox

19
History of Vaccination
  • 1798 - Edward Jenner noted
  • Smallpox and Cowpox
  • Milkmaids frequently contracted cowpox which
    caused lesions similar to that smallpox
  • Milkmaids who had cowpox almost never got
    smallpox
  • Jenners (unethical) experiment
  • Collected pus from cowpox sores
  • Injected cowpox pus into boy named James Phipps
  • Then injected Phipps with pus from smallpox sores
  • Phipps did not contract smallpox
  • First to introduce large scale, systematic
    immunization against smallpox

20
History of Vaccination
  • 1885 Attenuation
  • Louis Pasteur - first vaccine against rabies
  • Early 1900s Toxoids
  • Diphtheria, tetanus
  • 1936
  • Influenza
  • 1950s Tissue Culture
  • Polio (Nobel Prize for Enders, Robbins, Weller)
  • 1960s
  • Measles, Mumps, Rubella

21
Types of Vaccines
  • Non-infectious vaccines
  • Flu, plague
  • DTaP, Pneumococcus
  • Live, attenuated bacterial or viral vaccines
  • Chicken Pox, MMR
  • Carrier Vaccines
  • DNA Vaccines
  • Experimental

22
Non-infectious vaccines
  • Killed bacterial or inactivated viral vaccines
  • Treat pathogen with chemicals (like formaldehyde)
  • Impossible to guarantee that you have killed all
    the pathogen
  • Salk (inactivated) Polio vaccine, rabies vaccine
  • Subunit vaccines
  • Use part of pathogen OR
  • Use genetic engineering to manufacture pathogen
    protein
  • No danger of infection
  • Hepatitis A B, Haemophilus influenza type b,
    pneumonoccocal conjugate vaccines
  • Toxoid vaccines
  • Bacterial toxins that have been made harmless
  • Diphtheria, tetanus and pertussis vaccines
  • This approach will make memory B cells and memory
    helper T cells, but NOT memory killer T cells
  • Booster vaccines usually required

23
Live, attenuated vaccines
  • Grow pathogen in host cells in cell culture
  • Produces mutations which
  • Weaken pathogen so it cannot produce disease in
    healthy people
  • Pathogen still produces strong immune response
    that protects against future infection
  • This approach makes memory B cells, memory helper
    T cells, AND memory killer T cells
  • Usually provide life-long immunity
  • Ex. Sabin Polio vaccine (oral Polio)
  • Measles, mumps, rubella, varicella vaccines
  • Why is this a problem for immuno-compromised
    host?

24
Cell culture allows development of live,
attenuated vaccine
  • Grow cells
  • Removed from tissue
  • In vitro (in glass)
  • By supplying nutrients and other factors
  • Specific O2 and CO2 (pH level)
  • Glucose, ions
  • Serum from blood proteins

25
Passaging Cells
26
Carrier Vaccines
  • Use virus or bacterium that does not cause
    disease to carry viral genes to APCs
  • e.g. vaccinia for Smallpox vaccine
  • http//www.bt.cdc.gov/agent/smallpox/vaccination/f
    acts.asp
  • This approach makes memory B cells, memory helper
    T cells, AND memory killer T cells
  • Does not pose danger of real infection
  • Immuno-compromised individuals can get infection
    from carrier
  • Carrier must be one that individuals are not
    already immune to
  • Why cant you make a booster vaccine with carrier?

27
DNA Vaccines
  • DNA injections can produce memory B cells and
    memory T killer cells
  • Reasons are not fully understood
  • Make a DNA vaccine from a few viral genes
  • No danger that it would cause infection

28
Types of Vaccines
  • Non-infectious vaccines
  • No danger of infection
  • -- Does not stimulate cell mediated immunity
  • -- Usually need booster vaccines
  • Live, attenuated bacterial or viral vaccines
  • Makes memory B cells, memory helper T cells,
    AND memory killer T cells
  • Usually provides life-long immunity
  • -- Can produce disease in immuno-compromised host
  • Carrier Vaccines
  • Makes memory B cells, memory helper T cells,
    AND memory killer T cells
  • Does not pose danger of real infection
  • - Immuno-compromised individuals can get
    infection from carrier
  • DNA Vaccines
  • Experimental

29
Effectiveness of Vaccines
  • Vaccination Effectiveness
  • About 1-2 of every 20 people immunized will not
    have an adequate immune response to a vaccine
  • Herd Immunity
  • Vaccinated people have antibodies against a
    pathogen
  • They are much less likely to transmit that germ
    to other people
  • Even people that have not been vaccinated are
    protected
  • About 95 of community must be vaccinated to
    achieve herd immunity
  • Does not provide protection against
    non-contagious diseases eg tetanus

30
Your Flu Shot
  • If you got your flu shot this season, and skip it
    next season, you are more likely to get the flu
    next seasonWhy?

31
Vaccines
  • How Are They Tested?

32
Vaccine Testing
  • Laboratory testing
  • Animal Model
  • Animal must be susceptible to infection by agent
    against which vaccine is directed
  • Animal should develop same symptoms as humans

33
Vaccine Testing
  • Human Trials
  • Phase I
  • Small number of volunteers (20-100)
  • Usually healthy adults
  • Last few months
  • Determine vaccine dosages that produce levels of
    memory B or T cells that are likely to be
    protective
  • Evaluate side effects at these dosages
  • FDA must approve the vaccine as an
    Investigational New Drug (IND)
  • NPR Story Ebola Vaccine Trials
  • http//www.npr.org/rundowns/segment.php?wfId15132
    30

34
Vaccine Testing
  • Human Trials
  • Phase II
  • Larger number of volunteers (several hundred)
  • Last few months to few years
  • Controlled study, with some volunteers receiving
  • Vaccine
  • Placebo (or existing vaccine)
  • Endpoints Effectiveness, safety

35
Vaccine Testing
  • Human Trials
  • Phase III
  • Large number of volunteers (several hundred to
    several thousand)
  • Last years
  • Controlled double blind study, with some
    volunteers receiving
  • Vaccine
  • Placebo (or existing vaccine)
  • Neither patients nor physicians know which was
    given

36
Vaccine Testing
  • Role of the FDA
  • Licensure by FDA required before a company can
    market the vaccine (about a decade)
  • Each batch of vaccine must be tested for safety,
    potency, purity and sample lot must be sent to
    FDA
  • Post-licensure surveillance
  • Doctors must report adverse reactions after
    vaccination to FDA and CDC
  • Vaccine Adverse Events Reporting System (VAERS)
  • As many as 12,000 reports per year, 2,000 serious
  • Most are unrelated to the vaccine

37
Vaccine Testing
  • Recommendations by health departments and expert
    physician groups
  • When should vaccine be used
  • Who should receive it
  • Weigh risks and benefits of the vaccine, costs
    of vaccination
  • Legislation
  • States determine which vaccines are required by
    law
  • All 50 states have school immunization laws
  • Can be exempted based on
  • Medical reasons (50 states)
  • Religious reasons (48 states)
  • Philosophical reasons (15 states)

38
Vaccine Schedule
  • Birth
  • Hepatitis B
  • 2 Months
  • DTap 1
  • Polio 1
  • Hib 1
  • Hepatits B 2
  • Pneumococcus 1
  • 4 months
  • DTaP 2
  • Polio 2
  • Hib 2
  • Pneumococcus 2
  • 6 months
  • DTaP 3
  • Hib 3
  • Pneumococcus 3
  • 12 months
  • MMR 1
  • Varicella
  • 15 months
  • Hib 4
  • Polio 3
  • Hepatitis B 3
  • Pneumococcus 4
  • DTap 4
  • 4-6 years
  • MMR 2
  • Polio 4
  • DTaP 5
  • 11-12 years
  • Tetanus, Diphtheria

By age two 20 shots!! Single visit Up to 5
shots!!
http//www.christianpoint.org/inspiration/images/c
rying_baby.jpg
39
Recommended Vaccine Schedule
40
History of the Rotavirus Vaccine
  • Withdrawn from the market after post-licensure
    surveillance indicated small number of adverse
    effects

http//www.npr.org/templates/story/story.php?story
Id3262013 http//www.npr.org/templates/story/stor
y.php?storyId5126636
41
Vaccines
  • Are They Effective?

42
Effects of Vaccination in US
Disease Max of Cases Cases in 2000 D
Diphtheria 206,929 (1921) 2 -99.99
Measles 894,134 (1941) 63 -99.99
Mumps 152,209 (1968) 315 -99.80
Pertussis 265,269 (1952) 6,755 -97.73
Polio 21,269 (1952) 0 -100
Rubella 57,686 (1969) 152 -99.84
Tetanus 1,560 (1923) 26 -98.44
HiB 20,000 (1984) 1,212 - 93.14
Hep B 26,611 (1985) 6,646 -75.03
43
Effects of Vaccination
  • Smallpox
  • First human disease eradicated from the face of
    the earth by a global immunization campaign
  • 1974
  • Only 5 of the worlds children received 6
    vaccines recommended by WHO
  • 1994
  • gt80 of the worlds children receive basic
    vaccines
  • Each year 3 million lives saved

44
Smallpox
  • One of worlds deadliest diseases
  • Vaccine available in early 1800s
  • Difficult to keep vaccine viable enough to
    deliver in developing world
  • Elimination of smallpox
  • 1950 stable, freeze dried vaccine
  • 1950 Goal ? Eradicate smallpox from western
    hemisphere
  • 1967 Goal achieved except for Brazil
  • 1959 Goal ? Eradicate smallpox from globe
  • Little progress made until 1967 when resources
    dedicated, 10-15 million cases per year at this
    time
  • Strategies
  • Vaccinate 80 of population
  • Surveillance and containment of outbreaks
  • May 8, 1980 world certified as smallpox free

45
Childhood Immunization
  • 1977
  • Goal to immunize at least 80 of worlds children
    against six antigens by 1990
  • Measles
  • Diphtheria
  • Pertussis
  • Tetanus
  • Polio
  • Tuberculosis

46
Measles
Pertussis
47
Diptheria
48
http//www.npr.org/templates/story/story.php?story
Id849775
http//www.npr.org/templates/story/story.php?story
Id3870193
49
Vaccines
  • What is Still Needed?

50
What Vaccines are needed?
  • The big three
  • HIV
  • Malaria
  • Tuberculosis

51
Summary of Lecture 9
  • How do vaccines work?
  • Stimulate immunity without causing disease
  • How are vaccines made?
  • Non-infectious vaccines
  • Live, attenuated bacterial or viral vaccines
  • Carrier Vaccines
  • DNA Vaccines
  • How are vaccines tested?
  • Lab/Animal testing
  • Phase I-III human testing
  • Post-licensure surveillance
  • Impact of vaccines

52
  • Turn in Project Task 2 today
  • Next Time
  • HW 5 due on 2/13/07
  • HIV/AIDS vaccine development

53
To learn more
  • Influenza
  • http//www.cdc.gov/mmwr/mguide_flu.html
  • Avian Flu
  • http//www.cdc.gov/flu/avian/
  • http//www.pandemicflu.gov/
  • Original Antigenic Sin
  • http//www.rice.edu/sallyport/2003/fall/sallyport/
    flu.html
  • An overview of vaccines
  • http//www.accessexcellence.org/AE/AEC/CC/vaccines
    _how_why.html
Write a Comment
User Comments (0)
About PowerShow.com